DNMT3B and breast carcinoma: In a British population, the C46359T polymorphism in the DNMT3B promoter in breast cancer cases was reported by investigation of 352 breast cancer patients and 258 controls, indicating that individuals with T allele in DNMT3B have a high risk of breast cancer development (Montgomery et al., 2004).